A139. Purified coeliac disease patient serum IgA inhibits fibroblast and TGF-beta induced epithelial cell (T84) differentiation in vitro. (Tampere, Finland)
A140. Nitric oxide does not play a role in the initial mucosal response to the instillation of gluten into the rectum (Buenos Aires, Argentina)
A141, INOS expression in coeliac disease small-bovel biopsy tissue (Maastricht, the Netherlands)
A142. Increased urinary nitric oxide (NO) oxidation products in children with active coeliac disease (Maastricht, the Netherlands)
A143. Children with coeliac disease express iNOS in the small intestine epithelium (Norrköping, Sweden)
A144. Gluten stimulates NO production in children with coelic disease? (Norrköping, Sweden)
A145. Reduced Na+K+ Pump activity in the erythrocytes of children with treated coeliac disease (Budapest, Hungary)
A146.Changes in the expression of transcripts of the calcium-binding protein calbindin-D9K in duodenal biopsies in coeliac disease. (London, UK)
A147. The organe culture of human intestinal biopsies as an in vitro-model for coeliac disease in remission. (Düsseldorf, Germany)
A148. Integrins and coeliac disease.Pittschieler K, Ladinser B.
A149. Distinct distribution of sulphated glycosaminoglycans within coeliac mucosa, Simon Murch, Alan Phillips (London, UK)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157760/
A150. Enhanced gliadin peptide binding to intact small intestinal brush border membranes in coeliac disease. (Tübingen, Germany)
A151. Diversity of epitopes of coeliac disease autoantibodies (Leipzig, Germany)
A152. Studies on IgA-autoantibodies against fibroblast derived antigens in celiac disease (Uppsala, Sweden)
A153. Ig-A antibodies against human proteins in sera from coeliac patients determined by western blotting (uppsala, Sweden)
A154. Cross-reactivity of antigliadin antibodies in coeliac patients with enterocyte antigens (Edmonton, Canada) http://www.ncbi.nlm.nih.gov/pubmed/9400629
Vasta-aineita kalretikuliinia kohtaan. ( Tässä sivuhyppu. katsoin akertuuko kalretikuliini APP, Abeeta asioihinja se tarkertuu. Musiiin Mmeoryblogiin "Calretikuliini".
A155. Deficit in spontaneous IL-4 secretion by intraepithelial and laminapropria (LPL) lymphcytes from adult coeliac patients. (France) In conclusion: a defect of IL-4 secretion by intestinal lymphocytes could represent a primary immune dysfunction in adult coeliac disease.
A156. Cytokine production following gliadin stimulation of circulateing peripheral blood mononuclear cells (Maynooth, ireland)
A157. Soluble interleukin-2 (SIL-2R) receptor concentration in serum or children with coeliac disease before and after introduction of a gluten-free diet. (sIL-2R concentration coul be used as an additional method in the coeliac patient therapy response evaluation)
A158. Leukocyte aggregation and celiac disease. (Milan italy)
A159.IFN-gamma and IL-4 producin cells in blood of children with coeliac disease.(Uppsala, Sweden)
A160. Effect of alfa-gliadin on intestinal epithelial cell lines; a comparison with G+ and G- antigens( Paris, France)
A161 Gliadin specific, CD4+ T cells are frequntly found in the small intestinal mucosa of both celiac disease and dermatitis herpetiformis patients. (Oslo, Norway)
A162 Cellular immunity in coeliac disease (Thessaloniki, Greece)
A163. Specificity to cereal prolamines an HLA restriction of the T-cell clones isolated from jejunal mucosa of celiac patients.
A164. T-cell receptor (TCR) repertoire in coeliac disease (CD) conserved junctional sequences in the untreated mucosa (Naples, Italy)
A165. T-lymphocyte sub-populations in healthy human intestinal lamina propria. (Dublin, Ireland)
A166 Quantification of intraepithelial lymphocytes (IEL) subsets by flow cytometry analysis (FCA).
A167. Increased HLA-DR and decreased CD3 on human intestinal intraepithelial lymphocytes: evidence of activation. (Dublin, Ireland)
A168. Quantification of intraepithelial lymphocytes using computerised image analysis.
A169. Intraepithelial lymphocytes (IELs) in the celiac mucosa induce cell death (apoptosis) of enterocytes (Jerusalem, israel)
A170. T cell immune responses to gliadin in coeliac and normal individuals (Ireland)
A171. Immune response in vitro to human fibroblast-derived coeliac disease autoantigen is HLA DR/DQ restricted (Hki, Tre, Finalnd)
A172. Circulating CD45RO+ TcR gammadelta cells in coeliac disease patients and their healthy family members ( Hki, Tre, Finland)
A173. HLA-DQ2 as a marker of potential coeliac disease among first-degree relatives of coeliac patients 8Spain)
A174. Relationship between abnormal immunological parameters and the coeliac HLA haplotype in non-coeliac patients. (Edinburgh)
A175. TNF2, a polymorfism of the TNF.-alfa promoter, is a component of the coeliac disease haplotype.
A176. Restricted T-cell receptor Vbeta gene usage in the skin of patients with dermatitis herpetiformis(DH) . Conclusion: These results support the hypothesis that recognition of an antigen or superantigen is involved in the pathogenesis of DH skin lesions.
A177. Gliadin-induced enteropathy in rats affects activities of intestinal brush-border enzymes (Czech Republic)
Conclusion: Rat model of intestinal enteropathy revealed that alfa-glukosidases increased while lactase, dipeptidylpeptidase (DPP IV) and gamma-glutamyltranspeptidase (GGT) decreased after gliadin feeding to newbornd animals.
A178. Experimental model of coeliac disease in non-suckling, artificially fed rats. (Czech republic)
A179. DLA-DQ alleles in Irish setter dogs with naturally occuring gluten-sensitive enteropathy (London, UK)
A180. Jejunal leucocyte populations in the early stages of gluten sensitive enteropathy in Irish setter dogs. (London, UK)
A181. Lamina propria and intraepithelial leucocyte populations in Irish setter dogs with gluten sensitive enteropathy. (London, UK)